FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.24  |  FHIR Version n/a  User: [n/a]

18588211000001103: Neliprax 0.35mg tablets (Aspire Pharma Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 06-Apr 2011. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
63745201000001114 Neliprax 0.35mg tablets (Aspire Pharma Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
63745301000001117 Neliprax 0.35mg tablets (Aspire Pharma Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Neliprax 0.35mg tablets (Aspire Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Neliprax 0.35mg tablets (Aspire Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Neliprax 0.35mg tablets (Aspire Pharma Ltd) Is a Pramipexole 350microgram tablets true Inferred relationship Existential restriction modifier
Neliprax 0.35mg tablets (Aspire Pharma Ltd) Has active ingredient Pramipexole true Inferred relationship Existential restriction modifier
Neliprax 0.35mg tablets (Aspire Pharma Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Neliprax 0.35mg tablets (Aspire Pharma Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Neliprax 0.35mg tablets (Aspire Pharma Ltd) Has specific active ingredient Pramipexole dihydrochloride monohydrate false Inferred relationship Existential restriction modifier
Neliprax 0.35mg tablets (Aspire Pharma Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Neliprax 0.35mg tablets (Aspire Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Pramipexole true Inferred relationship Existential restriction modifier
Neliprax 0.35mg tablets (Aspire Pharma Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Neliprax 0.35mg tablets (Aspire Pharma Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Neliprax 0.35mg tablets (Aspire Pharma Ltd) Is a Neliprax true Inferred relationship Existential restriction modifier
Neliprax 0.35mg tablets (Aspire Pharma Ltd) Has manufactured dose form Tablet false Inferred relationship Existential restriction modifier
Neliprax 0.35mg tablets (Aspire Pharma Ltd) Has specific active ingredient Pramipexole dihydrochloride monohydrate true Inferred relationship Existential restriction modifier
Neliprax 0.35mg tablets (Aspire Pharma Ltd) Has basis of strength substance Pramipexole true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Neliprax 0.35mg tablets (Aspire Pharma Ltd) 30 tablet 3 x 10 tablets Has AMP True Neliprax 0.35mg tablets (Aspire Pharma Ltd) Inferred relationship Existential restriction modifier
Neliprax 0.35mg tablets (Aspire Pharma Ltd) 100 tablet 10 x 10 tablets Has AMP True Neliprax 0.35mg tablets (Aspire Pharma Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start